Pharming Group N.V. Overview
Get informed when a big investor buys or sells
+ Follow18.05
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, PHAR shows a PEG ratio of 18.05. That is above the Healthcare sector average of 12.15. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 12.15. Pharming Group N.V. is at 18.05, which is higher that average. That is roughly 48.5% above the sector mean. Use the comparison chart on this page to see how PHAR stacks up against individual peers as well.
Investors watch PHAR's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Pharming Group N.V.'s latest reading is 18.05. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Pharming Group N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 18.05) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 12.15, while PHAR is at 18.05. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
